Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Metabolic Syndrome Among Iranian Population: A Systematic Review and Meta-Analysis



Dalvand S1 ; Niksima SH2 ; Meshkani R3 ; Ghanei Gheshlagh R4 ; Sadeghnejadi S3 ; Kooti W5 ; Parizad N6 ; Zahednezhad H7 ; Afrisham R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
  2. 2. Dept. of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Dept. of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Dept. of Nursing, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran
  5. 5. Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
  6. 6. Dept. of Medical-Surgical Nursing, School of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran
  7. 7. Dept. of Nursing, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Source: Iranian Journal of Public Health Published:2017

Abstract

Background: Metabolic syndrome (MetS) is the major risk factor for development of type 2 diabetes and cardiovascular diseases in different populations. The aim of this study was to evaluate the prevalence of MetS among Iranian population. Methods: Thirty-four cross-sectional studies were analyzed with a sample of 83227 people. National and international English electronic databases (PubMed, Google scholar, Web of Science, Science Direct, and Scopus) and Persian language databases (SID, Medlib, Iran medex, Magiran, Medlib, and IranDoc) were used to search the articles published on MetS in Iranian population from Jan 2005 to May 2016. The MetS diagnosis was performed according to the ATP-III, NCEP/ATP-III, IDF and WHO criteria. Results: The overall weighted prevalence of MetS was 31% (95% CI: 28-35). According to ATP III criteria, total and gender-stratified prevalence of MetS in women and men were 29% (95% CI: 22-36), 37% (95% CI: 26-48) and 29% (95% CI: 23-36), respectively. Total prevalence of MetS based on NCEP/ATP III criteria was 29% (95% CI: 24-35) that the prevalence was 24% (95% CI: 18-30) and 35% (95% CI: 25-44) in men and women, respectively. According to the IDF and WHO criteria, total prevalence of MetS were 38% (95% CI: 32-43) and 30% (95% CI: 7-53), respectively. Conclusion: The findings demonstrate an emerging high prevalence of MetS in total and in particular among Iranian women population. Therefore, to minimize the risk of cardiovascular events in Iranian population, screening and early detection of risk factors for MetS are required. © 2017, Iranian Journal of Public Health. All rights reserved.
Other Related Docs
9. Metabolic Syndrome and Its Components Associated With Chronic Kidney Disease, Journal of Research in Medical Sciences (2015)